Add to Watchlist Create Alerts

Real-Time Last Update

Volume

Stocks in play: Medexus Pharmaceuticals

Baystreet.ca - Baystreet - Tue Apr 11, 2023

Announced preliminary revenue estimates for the company’s fourth fiscal quarter and full fiscal year ended March 31, 2023. Annual revenue is expected to exceed US$107 million for fiscal year ended March 31, 2023, an all-time record, including fiscal Q4 2023 revenue of at least US$28 million. Medexus Pharmaceuticals shares T.MDP are trading up $0.10 at $1.69.

Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe

The close: Stocks higher as investors focus on Fed moves

The close: Major North American indexes rise as megacap tech stocks rally

Why this money manager is venturing back into emerging markets and adding more U.S. tech

How a Canadian pirate-clad pastor helped ignite Trump Media’s market frenzy

report on business

Activist investor targets Dye & Durham’s ‘underperformance and strategic missteps’ in letter to shareholders

The close: U.S. stocks fall as GDP report spreads rate-cut gloom; Alphabet surges 15% in post market

report on business

Fiera Capital’s largest shareholder looks to sell stake in company

The close: S&P 500 higher as markets weigh rising bond yields and upbeat U.S. earnings; TSX lower as rails slide